Do heroin overdose patients require observation after receiving naloxone?

References

• Substance Abuse and Mental Health Services Administration, Center for Behavioral Health Statistics and Quality. Highlights of the 2011 Drug Abuse Warning Network (DAWN) Findings on Drug-Related Emergency Department Visits [Internet]. (2013, February 18) [cited 2015 Dec 31]. Available from: http://archive.samhsa.gov/data/2k13/DAWN127/sr127-DAWN-highlights.htm.
   Google Scholar
• Centers for Disease Control and Prevention. Wide-ranging Online Data for Epidemiologic Research (WONDER), Multiple-Cause-of-Death file, 2000–2014 [Internet]. 2015 [cited 2016 Jul 13]. Available from: http://www.cdc.gov/nchs/data/health_policy/AADR_drug_poisoning_involving_OA_Heroin_US_2000-2014.pdf.
   Google Scholar
• Center for Disease Control and Prevention. Prescription drug overdose data [Internet]. (2015, October 16) [cited 2016 Feb 18]. Available from: http://www.cdc.gov/drugoverdose/data/overdose.html.
   Google Scholar
• Jones CM, Logan J, Gladden RM, Bohm MK. Vital signs: demographic and substance use trends among heroin users — United States, 2002–2013. Morb Mortal Wkly Rep. 2015;64:719–725.
   PubMed Web of Science ®Google Scholar
• Boyer EW. Management of opioid analgesic overdose. N Engl J Med. 2012;367:146–155.
   PubMed Web of Science ®Google Scholar
• Vilke GM, Sloane C, Smith AM, et al. Assessment for deaths in out-of-hospital heroin overdose patients treated with naloxone who refuse transport. Acad Emerg Med. 2003;10:893–896.
   PubMed Web of Science ®Google Scholar
• Vilke GM, Buchanan J, Dunford JV, et al. Are heroin overdose deaths related to patient release after prehospital treatment with naloxone? Prehosp Emerg Care. 1999;3:183–186.
   PubMedGoogle Scholar
• Boyd JJ, Kuisma MJ, Alaspaa AO, et al. Recurrent opioid toxicity after pre-hospital care of presumed heroin overdose patients. Acta Anaesthesiol Scand. 2006;50:1266–1270.
   PubMed Web of Science ®Google Scholar
• Buajordet I, Naess AC, Jacobsen D, et al. Adverse events after naloxone treatment of episodes of suspected acute opioid overdose. Eur J Emerg Med. 2004;11:19–23.
   PubMed Web of Science ®Google Scholar
• Heyerdahl F, Hovda KE, Bjornaas MA, et al. Pre-Hospital treatment of acute poisonings in Oslo. BMC Emerg Med. 2008;8:15–23.
   PubMedGoogle Scholar
• Wampler DA, Molina K, McManus J, et al. No deaths associated with patient refusal of transport after naloxone-reversed opioid overdose. Prehosp Emerg Care. 2011;15:320–324.
   PubMed Web of Science ®Google Scholar
• Rudolph SS, Jehu G, Nielsen SL, et al. Prehospital treatment of opioid overdose in Copenhagen-is it safe to discharge on-scene? Resuscitation. 2011;82:1414–1418.
   PubMed Web of Science ®Google Scholar
• Levine M, Sanko S, Eckstein M. Assessing the risk of prehospital administration of naloxone with subsequent refusal of care. Prehosp Emerg Care. 2016;20:566–569.
   PubMed Web of Science ®Google Scholar
• Christenson J, Etherington J, Grafstein E, et al. Early discharge of patients with presumed opioid overdose: development of a clinical prediction rule. Acad Emerg Med. 2000;7:1110–1118.
   PubMed Web of Science ®Google Scholar
• Larpin R, Vincent A, Perret C. Hospital morbidity and mortality of acute opiate intoxication. Presse Med. 1990;19:1403–1406.
   PubMed Web of Science ®Google Scholar
• Smith DA, Leake L, Loflin JR, et al. Is admission after intravenous heroin overdose necessary? Ann Emerg Med. 1992;21:34–38.
   Web of Science ®Google Scholar
• Watson WA, Steele MT, Muelleman RL, et al. Opioid toxicity recurrence after an initial response to naloxone. Clin Toxicol. 1998;36:11–17.
   Web of Science ®Google Scholar
• Sporer KA, Firestone J, Isaacs M. Out-of-hospital treatment of opioid overdoses in an urban setting. Acad Emerg Med. 1996;3:660–667.
   PubMed Web of Science ®Google Scholar
• Doe-Simkins M, Quinn E, Xuan Z, et al. Overdose rescues by trained and untrained participants and change in opioid use among substance-using participants in overdose education and naloxone distribution programs: a retrospective cohort study. BMC Public Health. 2014;14:297. doi: 10.1186/1471-2458-14-297.
   PubMed Web of Science ®Google Scholar
• Bazazi AR, Zaller ND, Fu JJ, et al. Preventing opiate overdose deaths: examining objections to take-home naloxone. J Health Care Poor Underserved. 2010;21:1108–1113.
   PubMed Web of Science ®Google Scholar
• Smith S. Addicts To Receive Overdose Antidote [Internet]. Media Awareness Project. Boston, MA: Boston Globe. 2007, November 2 [cited 2016 Feb 18]. Available from: http://www.mapinc.org/drugnews/v07/n1283/a07.html?1079.
   Google Scholar
• Clark AK, Wilder CM, Winstanley EL. A systematic review of community opioid overdose prevention and naloxone distribution programs. J Addict Med. 2014;8:153–163.
   PubMed Web of Science ®Google Scholar
• Piper TM, Stancliff S, Rudenstine S, et al. Evaluation of a naloxone distribution and administration program in New York City. Subst Use Misuse. 2008;43:858–870.
   PubMed Web of Science ®Google Scholar
• Enteen L, Bauer J, McLean R, et al. Overdose prevention and naloxone prescription for opioid users in San Francisco. J Urban Health. 2010;87:931–941.
   PubMed Web of Science ®Google Scholar
• Walley AY, Xuan Z, Hackman HH, et al. Opioid overdose rates and implementation of overdose education and nasal naloxone distribution in Massachusetts: interrupted time series analysis. BMJ. 2013;346:f174.
   PubMed Web of Science ®Google Scholar
• Maxwell S, Bigg D, Stanczykiewicz K, et al. Prescribing naloxone to actively injecting heroin users: a program to reduce heroin overdose deaths. J Addict Dis. 2006;25:89–96.
   PubMed Web of Science ®Google Scholar
• Wagner KD, Valente TW, Casanova M, et al. Evaluation of an overdose prevention and response training programme for injection drug users in the Skid Row area of Los Angeles, CA. Int J Drug Pol. 2010;21:186–193.
   PubMed Web of Science ®Google Scholar
• Bailey AM, Wermeling DP. Naloxone for opioid overdose prevention: pharmacists' role in community-based practice settings. Ann Pharmacother. 2014;48:601–606.
   PubMed Web of Science ®Google Scholar
• Seal KH, Downing M, Kral AH, et al. Attitudes about prescribing take-home naloxone to injection drug users for the management of heroin overdose: a survey of street-recruited injectors in the San Francisco Bay Area. J Urban Health. 2003;80:291–301.
   PubMed Web of Science ®Google Scholar
• Seal KH, Thawley R, Gee L, et al. Naloxone distribution and cardiopulmonary resuscitation training for injection drug users to prevent heroin overdose death: a pilot intervention study. J Urban Health. 2005;82:303–311.
   PubMed Web of Science ®Google Scholar
• Galea S, Worthington N, Piper TM, et al. Provision of naloxone to injection drug users as an overdose prevention strategy: early evidence from a pilot study in New York City. Addict Behav. 2006;31:907–912.
   PubMed Web of Science ®Google Scholar
• Tracy M, Piper TM, Ompad D, et al. Circumstances of witnessed drug overdose in New York City: implications for intervention. Drug Alcohol Depend. 2005;79:181–190.
   PubMed Web of Science ®Google Scholar
• Davis CS, Ruiz S, Glynn P, et al. Expanded access to naloxone among firefighters, police officers, and emergency medical technicians in Massachusetts. Am J Public Health. 2014;104:e7–e9.
   PubMed Web of Science ®Google Scholar
• McDonald R, Strang J. Are take-home naloxone programmes effective? Systematic review utilizing application of the Bradford Hill criteria. Addiction. 2016;111:1177–1187.
   PubMed Web of Science ®Google Scholar
• Coffin PO, Sullivan SD. Cost-effectiveness of distributing naloxone to heroin users for lay overdose reversal. Ann Intern Med. 2013;158:1–9.
   PubMed Web of Science ®Google Scholar